Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background Due to the progressive nature of twin-to-twin transfusion syndrome (TTTS), hindering on health care access during the coronavirus disease (COVID-19) pandemic may lead to delayed diagnosis and referral to fetal surgery centers, which may have repercussions on outcomes. Objective To assess the clinical impact of the COVID-19 pandemic on pregnancies complicated with TTTS. Study Design A retrospective cohort of consecutive monochorionic diamniotic twin pregnancies complicated with TTTS evaluated in our national referral fetal surgery center at Queretaro, Mexico for possible surgical fetoscopy was constructed. Maternal-fetal characteristics and perinatal outcomes of cases evaluated during the first year of the World Health Organization's COVID-19 pandemic declaration (11 March 2020- 10 March 2021) were retrospectively compared with cases evaluated during the same period in the previous year (11 March 2019 – 10 March 2020). Results 109 consecutive TTTS cases were evaluated during the 2-year study period, 54 during the COVID-19 pandemic and 55 in the previous year. In the former group, a higher proportion of cases with fetal surveillance interval longer than 2 weeks (70.4% vs. 47.3%, p=0.01), TTTS complications precluding laser therapy such as intrauterine fetal demise, preterm rupture of membranes, or cervical dilatation with prolapsed amniotic membranes (18.5% vs. 1.8%, p<0.01), advanced TTTS (53.7% vs. 36.4%, p=0.07), preoperative short cervix (25.9% vs. 10.9%, p<0.05), and lower overall perinatal survival (56.9% vs. 80.0%, p=0.01 of at least one twin; and 39.2% vs. 56.4%, p=0.08 of both twins, respectively) were observed. A significantly lower number of cases were selected for fetoscopic laser therapy during the pandemic period (75.9% vs. 92.7%, p=0.01), with similar postoperative outcomes seen in both study periods. Conclusion In pregnancies with TTTS, the COVID-19 pandemic has shown an adverse impact involving suboptimal fetal surveillance, advanced stages at diagnosis, poorer survival rates, and higher number of complications that preclude fetoscopic laser therapy.
Background Due to the progressive nature of twin-to-twin transfusion syndrome (TTTS), hindering on health care access during the coronavirus disease (COVID-19) pandemic may lead to delayed diagnosis and referral to fetal surgery centers, which may have repercussions on outcomes. Objective To assess the clinical impact of the COVID-19 pandemic on pregnancies complicated with TTTS. Study Design A retrospective cohort of consecutive monochorionic diamniotic twin pregnancies complicated with TTTS evaluated in our national referral fetal surgery center at Queretaro, Mexico for possible surgical fetoscopy was constructed. Maternal-fetal characteristics and perinatal outcomes of cases evaluated during the first year of the World Health Organization's COVID-19 pandemic declaration (11 March 2020- 10 March 2021) were retrospectively compared with cases evaluated during the same period in the previous year (11 March 2019 – 10 March 2020). Results 109 consecutive TTTS cases were evaluated during the 2-year study period, 54 during the COVID-19 pandemic and 55 in the previous year. In the former group, a higher proportion of cases with fetal surveillance interval longer than 2 weeks (70.4% vs. 47.3%, p=0.01), TTTS complications precluding laser therapy such as intrauterine fetal demise, preterm rupture of membranes, or cervical dilatation with prolapsed amniotic membranes (18.5% vs. 1.8%, p<0.01), advanced TTTS (53.7% vs. 36.4%, p=0.07), preoperative short cervix (25.9% vs. 10.9%, p<0.05), and lower overall perinatal survival (56.9% vs. 80.0%, p=0.01 of at least one twin; and 39.2% vs. 56.4%, p=0.08 of both twins, respectively) were observed. A significantly lower number of cases were selected for fetoscopic laser therapy during the pandemic period (75.9% vs. 92.7%, p=0.01), with similar postoperative outcomes seen in both study periods. Conclusion In pregnancies with TTTS, the COVID-19 pandemic has shown an adverse impact involving suboptimal fetal surveillance, advanced stages at diagnosis, poorer survival rates, and higher number of complications that preclude fetoscopic laser therapy.
Objectives To report the outcome of fetuses with a prenatal diagnosis of congenital lung malformation (CLM) diagnosed on ultrasound by performing a comprehensive assessment of these outcomes through a systematic review and meta-analysis. Content CLMs are a heterogeneous group of anomalies that involve the lung parenchyma and its bronchovascular structures. Their presentation and evolution are variable, from entirely asymptomatic lesions with sonographic regression in utero to hydropic fetuses requiring fetal therapy, intrauterine death or neonatal morbidity. A systematic review was conducted in Medline, Embase and Cochrane databases including studies on fetuses with CLM diagnosed prenatally in order to report the in-utero natural history of these lesions. Thirty-nine studies (2,638 fetuses) were included in the final review. Summary Regression/reduction in size of the lung lesion during pregnancy was reported in 31 % of cases, while its increase in 8.5 % of cases. Intra-uterine death complicated 1.5 % of pregnancies with fetal CLM, while neonatal and perinatal death were 2.2 and 3 %, respectively. Neonatal morbidity occurred in 20.6 % of newborns with CLM; 46 % had surgery, mainly elective. In fetuses with CLM and hydrops, fetal/perinatal loss occurred in 42 %. Assessment of the role of fetal therapy in improving the outcomes of pregnancies complicated by CLM was hampered by the small number of included cases and heterogeneity of type of interventions. Outlook Fetuses with CLM prenatally diagnosed have a generally favorable outcome. Conversely, there is a low quality of evidence on the actual role of fetal therapy in improving the outcome of fetuses presenting with these anomalies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.